Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 143

    1.

    Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea.

    Wilson S.

    Ann Intern Med. 2000 Dec 5;133(11):925-6. No abstract available. PMID: 11103075 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Are we underestimating the leukemogenic risk of hydroxyurea.

    Al-Jam'a AH, Al-Dabbous IA, Al-Khatti AA, Esan FG.

    Saudi Med J. 2002 Nov;23(11):1411-3.PMID: 12506308 [PubMed - indexed for MEDLINE]Related articles

    3.

    Malignancies in sickle cell disease patients treated with hydroxyurea.

    Ferster A, Sariban E, Meuleman N; Belgian Registry of Sickle Cell Disease patients treated with Hydroxyurea.

    Br J Haematol. 2003 Oct;123(2):368-9. No abstract available. PMID: 14531924 [PubMed - indexed for MEDLINE]Related articles

    4.

    Long-term use of hydroxyurea for sickle cell anemia.

    Spell DW.

    JAMA. 2003 Aug 13;290(6):752; author reply 754. No abstract available. PMID: 12915422 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hydroxyurea for sickle cell anemia.

    Bachmeyer C, Aractingi S, Lionnet F.

    N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9. No abstract available. PMID: 18609755 [PubMed - indexed for MEDLINE]Related articles

    6.

    Hydroxyurea-induced splenic regrowth in an adult patient with severe hemoglobin SC disease.

    Huang Y, Ananthakrishnan T, Eid JE.

    Am J Hematol. 2003 Oct;74(2):125-6.PMID: 14508799 [PubMed - indexed for MEDLINE]Related articles

    7.

    Hydroxyurea for the treatment of sickle cell anemia.

    Platt OS.

    N Engl J Med. 2008 Mar 27;358(13):1362-9. Review. No abstract available. PMID: 18367739 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hydroxyurea in very young children with sickle cell anemia is not a cure-all.

    Powars DR.

    J Pediatr. 2001 Dec;139(6):763-4. No abstract available. PMID: 11743496 [PubMed - indexed for MEDLINE]Related articles

    9.

    Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy.

    O'branski EE, Ware RE, Prose NS, Kinney TR.

    J Am Acad Dermatol. 2001 May;44(5):859-61.PMID: 11312437 [PubMed - indexed for MEDLINE]Related articles

    10.

    Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment.

    Fattori A, de Souza RA, Saad ST, Costa FF.

    Hematol J. 2005;5(7):589-90.PMID: 15692605 [PubMed - indexed for MEDLINE]Related articles

    11.

    Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.

    Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE.

    Blood. 1999 Sep 1;94(5):1550-4.PMID: 10477679 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.

    Olujohungbe A, Cinkotai KI, Yardumian A.

    BMJ. 1998 Jun 6;316(7146):1689. No abstract available. PMID: 9614013 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. French Study Group on Sickle Cell Disease.

    de Montalembert M, Bégué P, Bernaudin F, Thuret I, Bachir D, Micheau M.

    Arch Dis Child. 1999 Nov;81(5):437-9.PMID: 10519721 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Sickle cell pain crisis.

    Davies SC, Bevan DH.

    Lancet. 1996 Jan 27;347(8996):263. No abstract available. PMID: 8551907 [PubMed - indexed for MEDLINE]Related articles

    15.

    National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.

    Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, James AH, Laraque D, Mendez M, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M.

    Ann Intern Med. 2008 Jun 17;148(12):932-8. Epub 2008 May 5. No abstract available. PMID: 18458271 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Edifying affair of hydroxycarbamid]

    Nau JY.

    Rev Med Suisse. 2008 Apr 9;4(152):940. French. No abstract available. PMID: 18578439 [PubMed - indexed for MEDLINE]Related articles

    17.

    The role of hydroxyurea in sickle cell disease.

    Halsey C, Roberts IA.

    Br J Haematol. 2003 Jan;120(2):177-86. Review. No abstract available. Erratum in: Br J Haematol. 2003 Apr;121(1):200. PMID: 12542474 [PubMed - indexed for MEDLINE]Related articles

    18.

    When should hydroxyurea be used for children with sickle cell disease?

    Mueller BU.

    Pediatrics. 2008 Dec;122(6):1365-6. No abstract available. PMID: 19047256 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.

    Chaine B, Neonato MG, Girot R, Aractingi S.

    Arch Dermatol. 2001 Apr;137(4):467-70.PMID: 11295927 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

    Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

    Ann Intern Med. 2008 Jun 17;148(12):939-55. Epub 2008 May 5. Review.PMID: 18458272 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data